EU PHAMACUETICAL MANUFACTURERS RAIL AGAINST PROPOSED PHARMACOVIGILANCE FEES

BY KEITH NUTHALL THE EUROPEAN Federation of Pharmaceutical Industries and Associations (EFPIA) has attacked proposed fees charged to pharma manufacturers for pharmacovigilance work undertaken by the European Medicines Agency (EMA) and associated bodies. In September, the European Commission tabled a series of fees - some high. For instance, some pharmacovigilance referrals would incur fees ranging from Euro EUR80,300 to EUR267,400. Replying, the EFPIA opposed Brussels' suggestion that the pharma sector should cover all pharmacovigilance costs. "We consider ...


Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.